Enablex - 0430-0170-23 - (darifenacin)

Alphabetical Index


Drug Information of Enablex

Product NDC: 0430-0170
Proprietary Name: Enablex
Non Proprietary Name: darifenacin
Active Ingredient(s): 7.5    mg/1 & nbsp;   darifenacin
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Enablex

Product NDC: 0430-0170
Labeler Name: Warner Chilcott (US), LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021513
Marketing Category: NDA
Start Marketing Date: 20041222

Package Information of Enablex

Package NDC: 0430-0170-23
Package Description: 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0430-0170-23)

NDC Information of Enablex

NDC Code 0430-0170-23
Proprietary Name Enablex
Package Description 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0430-0170-23)
Product NDC 0430-0170
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name darifenacin
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20041222
Marketing Category Name NDA
Labeler Name Warner Chilcott (US), LLC
Substance Name DARIFENACIN HYDROBROMIDE
Strength Number 7.5
Strength Unit mg/1
Pharmaceutical Classes Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]

Complete Information of Enablex


General Information